1 Min Read
Sept 19 (Reuters) - Amylyx Pharmaceuticals Corp:
* Amylyx Pharmaceuticals receives FDA orphan drug designation for AMX0035 for the treatment of amyotrophic lateral sclerosis Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.